Iran Begins Clinical Trials of Domestically Developed COVID-19 Vaccine
[Asia Economy Reporter Jeon Jinyoung] Iran has begun clinical trials of its domestic novel coronavirus (COVID-19) vaccine 'Coviran' (Coviran·Covid+Iran).
According to the Associated Press on the 29th (local time), Iran's state-owned pharmaceutical company, Sipa Pharmed, plans to administer the vaccine to 56 volunteers. The company explained that the vaccine is given twice at two-week intervals, and antibody formation can be assessed one month after the second dose.
Coviran is an inactivated vaccine using weakened or dead viruses. Iranian authorities expect that if the clinical trials proceed smoothly, the vaccine could be commercialized by late spring next year.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
According to the Iranian Ministry of Health, as of the 29th, the cumulative number of COVID-19 confirmed cases is about 1.21 million, ranking 15th worldwide, and the death toll is about 54,900, ranking 8th.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
